Blog Comments

Kinetica Online is pleased to provide direct links to commentaries from our senior editor Dr. Steven Pelech has posted on other blogs sites. Most of these comments appear on the GenomeWeb Daily Scan website, which in turn highlight interesting blogs that have been posted at numerous sites in the blogosphere since the beginning of 2010. A wide variety of topical subjects are covered ranging from the latest scientific breakthroughs, research trends, politics and career advice. The original blogs and Dr. Pelech’s comments are summarized here under the title of the original blog. Should viewers wish to add to these discussions, they should add their comments at the original blog sites.

The views expressed by Dr. Pelech do not necessarily reflect those of the other management and staff at Kinexus Bioinformatics Corporation. However, we wish to encourage healthy debate that might spur improvements in how biomedical research is supported and conducted.

Publications

Too Much to Read

Blogger Pedro Beltrao at Public Rambling noted that 848,865 papers were added to PubMed in 2009, and he says that there needs to be improvements in how researchers are able to find the publications that are particular important to them. S. Pelech proposes that we need to completely re-think and re-engineer how we disseminate the data from scientific research so that it is more efficiently found and utilized in databases that are directly queryable. Read More...

The Rise of Asia

The Economist reported that in 1990, North America, Europe, and Japan carried out more than 95 percent of the R&D done in the world, and by 2007 that number had dropped to 76 percent, while China's spending on R&D is skyrocketing and the number of scientists there is set to overtake both the US and the EU. S. Pelech comments that while much of the research in North America is actually performed by Asian researchers living abroad, and it is actually nice to see places like China and India contribute more to the growth of global biomedical research, because ultimately we will all benefit in terms of improved diagnostics and therapeutics as well as new knowledge. Read More...